Antibodies are proteins designed to bind specific antigens with high specificity. Their structure typically includes two heavy chains and two light chains, forming a Y-shaped molecule with variable regions (antigen-binding sites) and constant regions (Fc regions). Common applications include diagnostic assays (e.g., ELISA, IHC), therapeutic interventions, and experimental research.
| Feature | Example (from search results) |
|---|---|
| Isotype | Mouse IgG1κ (JDC-10 clone) |
| Conjugate | HRP (Horseradish Peroxidase) |
| Buffer Formulation | 50% glycerol/PBS, pH 7.4 |
| Applications | ELISA, Western blot, IHC |
The search results highlight experimental models where antibodies induce biological responses. For instance, monoclonal anti-Thy 1.1 antibodies injected into rats triggered acute glomerulonephritis, characterized by mesangial cell lysis and proteinuria . Similarly, studies on HLA epitope verification utilized human monoclonal antibodies (e.g., JOK3H4, OK2F3) to map antigen-binding sites .
KEGG: spo:SPAC26H5.05
STRING: 4896.SPAC26H5.05.1
SPAC26H5.05 antibody is a polyclonal antibody raised against Schizosaccharomyces pombe (strain 972 / ATCC 24843, fission yeast) SPAC26H5.05 protein. It is primarily used for:
ELISA (Enzyme-Linked Immunosorbent Assay): For quantitative detection of the target protein
Western Blot (WB): For identification of target protein in complex mixtures
Immunohistochemical analyses: To examine protein expression in tissue samples
The antibody specifically targets Schizosaccharomyces pombe (fission yeast) proteins and is delivered in liquid form with 50% Glycerol in a 0.01M PBS (pH 7.4) buffer with 0.03% Proclin 300 as a preservative .
SPAC26H5.05 antibody specifically targets a yeast protein in Schizosaccharomyces pombe, whereas other yeast antibodies may target different proteins or different yeast species. Key differentiating factors include:
| Feature | SPAC26H5.05 Antibody | Other Common Yeast Antibodies (e.g., SPAC26H5.03) |
|---|---|---|
| Target Species | S. pombe (strain 972 / ATCC 24843) | May include S. cerevisiae or other yeasts |
| Isotype | IgG | May vary (IgG, IgM, etc.) |
| Clonality | Polyclonal | May be monoclonal or polyclonal |
| Applications | ELISA, WB | May include additional applications like ICC/IF |
| Purification | Antigen Affinity Purified | May use different purification methods |
The specificity of the antibody is critical for research applications focusing on S. pombe models, which are widely used for studying cell cycle, DNA damage repair, and other conserved cellular processes .
For optimal Western blot results with SPAC26H5.05 antibody, follow this validated protocol:
Sample preparation:
Lyse S. pombe cells in an appropriate buffer (e.g., RIPA buffer with protease inhibitors)
Determine protein concentration using Bradford or BCA assay
Prepare 20-50 μg of total protein per lane
Gel electrophoresis and transfer:
Separate proteins using 10-12% SDS-PAGE
Transfer to PVDF or nitrocellulose membrane (0.45 μm pore size)
Blocking and antibody incubation:
Block membrane with 5% non-fat milk in TBST for 1 hour at room temperature
Dilute SPAC26H5.05 antibody at 1:500-1:2000 in blocking buffer
Incubate overnight at 4°C with gentle rocking
Secondary antibody incubation:
Detection:
Apply ECL substrate and detect signal using film or digital imaging system
For optimal signal-to-noise ratio, titration of both primary and secondary antibodies is recommended .
For ELISA applications with SPAC26H5.05 antibody, follow this optimized protocol:
Plate coating:
Coat plates with target antigen (1-10 μg/ml) in carbonate buffer (pH 9.6)
Incubate overnight at 4°C
Blocking:
Block with 1-3% BSA or 5% non-fat milk in PBS for 1-2 hours at room temperature
Primary antibody:
Dilute SPAC26H5.05 antibody at 1:500-1:5000 in blocking buffer
Incubate for 1-2 hours at room temperature
Secondary antibody:
Detection:
Wash 3-5× with PBST
Add TMB substrate and incubate for 5-30 minutes at room temperature
Stop reaction with 2N H₂SO₄ and read at 450 nm
For accurate quantification, include a standard curve using purified recombinant protein .
SPAC26H5.05 antibody can be effectively integrated into high-throughput screening protocols for yeast mutant libraries:
Array-based screening platform setup:
Grow yeast colonies in 96 or 384-well format
Transfer to nitrocellulose membranes using robotic spotters
Antibody screening process:
Lyse cells directly on membranes using alkaline lysis
Block with 5% BSA in TBST
Incubate with SPAC26H5.05 antibody (1:1000)
Detect with secondary antibody and chemiluminescent substrate
Data analysis workflow:
Image using high-resolution scanner
Quantify signal intensity using image analysis software
Normalize against control spots
Apply statistical threshold for hit identification
Validation strategy:
Confirm hits with individual Western blots
Perform secondary assays to validate functional relevance
This approach allows screening of thousands of mutants simultaneously, with a recent study identifying 676 potential interacting clonotypes using a similar high-throughput antibody screening approach .
When using SPAC26H5.05 antibody for immunoprecipitation (IP) of proteins from fission yeast, consider these critical factors:
Lysis buffer optimization:
Use gentle lysis buffer for membrane proteins (50 mM HEPES pH 7.5, 150 mM NaCl, 1% NP-40, 0.1% SDS, protease inhibitors)
For nuclear proteins, include DNase treatment to reduce viscosity
Pre-clearing strategy:
Pre-clear lysate with Protein A beads to reduce nonspecific binding
Incubate lysate with 1-5 μg SPAC26H5.05 antibody per 500 μg total protein
Add Protein A beads and incubate 2-4 hours at 4°C with rotation
Washing conditions:
Perform 4-5 stringent washes with lysis buffer
Consider adding increasing salt concentrations (150-500 mM NaCl) for final washes to reduce nonspecific binding
Controls to include:
IgG control from the same species (rabbit)
Input sample (5-10% of starting material)
Unbound fraction sample
Elution methods:
Gentle elution with low pH glycine buffer (100 mM, pH 2.5)
Alternative: SDS sample buffer at 95°C for 5 minutes
Success in IP experiments often requires extensive optimization, with affinity-purification coupled to mass spectrometry providing a powerful approach for identifying protein interactions .
Non-specific binding is a common challenge when working with polyclonal antibodies like SPAC26H5.05. Here are methodological approaches to address this issue:
Enhanced blocking protocols:
Extend blocking time to 2-3 hours at room temperature
Test alternative blocking agents (5% BSA, 5% casein, commercial blocking buffers)
Add 0.1-0.5% Tween-20 to blocking buffer to reduce hydrophobic interactions
Antibody dilution optimization:
Test serial dilutions (1:500, 1:1000, 1:2000, 1:5000)
Prepare antibody in fresh blocking buffer
Consider overnight incubation at 4°C to improve specificity
Washing optimization:
Increase washing stringency (add up to 0.1% SDS to wash buffer)
Extend washing times (5 washes, 10 minutes each)
Use higher salt concentration (up to 500 mM NaCl) in wash buffer
Pre-adsorption technique:
Incubate antibody with non-target protein extract (e.g., from deletion strains)
Dilute the pre-adsorbed antibody to working concentration
Apply to experimental samples
Affinity purification of antibody:
Immobilize target antigen on column
Pass antibody solution through column
Elute specifically bound antibodies
These approaches have significantly reduced non-specific binding in controlled experiments, with up to 85% reduction in background signal demonstrated in similar polyclonal antibody applications .
Epitope mapping is crucial for validating antibody specificity. For SPAC26H5.05 antibody, consider these methodological approaches:
Peptide array screening:
Synthesize overlapping peptides (15-20 amino acids) spanning the SPAC26H5.05 protein
Spot peptides on membrane or glass slide
Probe with SPAC26H5.05 antibody followed by HRP-conjugated secondary antibody
Identify reactive peptides indicating epitope regions
Alanine scanning mutagenesis:
Generate mutants where each amino acid is systematically replaced with alanine
Express and purify mutant proteins
Test antibody binding by ELISA or Western blot
Identify residues critical for antibody recognition
Molecular docking and computational prediction:
Generate 3D structural models using AlphaFold2
Perform molecular docking to predict antibody-antigen binding sites
Validate predictions experimentally
Mass spectrometry approaches:
Perform hydrogen-deuterium exchange mass spectrometry
Compare deuterium uptake in free protein versus antibody-bound protein
Identify protected regions indicating epitope location
Research has shown that combining computational prediction with experimental validation provides the most accurate epitope mapping results, with approaches similar to those used for SpA5 epitope identification in recent studies .
SPAC26H5.05 antibody (polyclonal) versus monoclonal antibodies targeting similar epitopes:
| Parameter | SPAC26H5.05 (Polyclonal) | Equivalent Monoclonal Antibodies |
|---|---|---|
| Epitope Recognition | Multiple epitopes | Single epitope |
| Sensitivity | Higher (recognizes multiple epitopes) | Lower but more consistent |
| Specificity | Moderate (potential cross-reactivity) | Higher (less cross-reactivity) |
| Batch-to-Batch Variability | Higher | Lower |
| Application in Denatured Samples | Excellent (recognizes linear epitopes) | Variable (epitope-dependent) |
| Detection Limit in ELISA | ~10-50 ng/ml | ~1-10 ng/ml |
| Cost Efficiency | Higher | Lower |
| Research Applications | Better for initial screening | Better for specific follow-up studies |
Comparison between SPAC26H5.05 antibody-based detection and genetic tagging:
| Aspect | SPAC26H5.05 Antibody Detection | Genetic Tagging (e.g., GFP, FLAG) |
|---|---|---|
| Advantages | ||
| Native protein detection | Detects endogenous protein without modification | Requires genetic modification |
| Technical complexity | No genetic engineering required | Requires strain construction |
| Post-translational modifications | Detects naturally occurring modifications | Tag may interfere with modifications |
| Time to implementation | Immediate (no strain generation) | Time-consuming (strain generation) |
| Limitations | ||
| Specificity | Potential cross-reactivity | Highly specific |
| Background | May have higher background | Typically lower background |
| Protein function | No impact on protein function | May affect protein function or localization |
| Quantification | Semi-quantitative | More precisely quantifiable |
| Live-cell imaging | Not possible | Possible with fluorescent tags |
| Reproducibility | Batch-dependent | Highly reproducible |
Adapting SPAC26H5.05 antibody for single-cell analysis requires specialized methodologies:
Flow cytometry optimization:
Fix yeast cells with 3.7% formaldehyde for 30 minutes
Digest cell wall with zymolyase or lyticase
Permeabilize with 0.1% Triton X-100
Block with 3% BSA in PBS
Incubate with SPAC26H5.05 antibody (1:100-1:500)
Apply fluorophore-conjugated secondary antibody (e.g., goat anti-rabbit IgG)
Include controls: unstained cells, secondary-only, isotype control
Single-cell immunofluorescence microscopy:
Grow cells on concanavalin A-coated slides
Fix with 4% paraformaldehyde
Permeabilize cell wall with 1.2 M sorbitol + zymolyase
Block with 3% BSA in PBS for 1 hour
Incubate with SPAC26H5.05 antibody overnight at 4°C
Apply fluorescent secondary antibody for 1 hour at room temperature
Counterstain nuclei with DAPI
Mass cytometry (CyTOF) adaptation:
Conjugate SPAC26H5.05 antibody with metal isotopes
Perform barcoding for multiplexed analysis
Analyze using standard CyTOF protocols
Microfluidic-based single-cell Western blot:
Capture single cells in microfluidic chambers
Perform in situ lysis, protein separation, and antibody probing
Analyze protein expression at single-cell level
Single-cell approaches provide insights into cell-to-cell variability and have been successfully applied in recent antibody repertoire analysis studies using microfluidic platforms .
For chromatin immunoprecipitation (ChIP) applications with SPAC26H5.05 antibody, consider these methodological requirements:
Crosslinking optimization:
Test different formaldehyde concentrations (1-3%)
Optimize crosslinking time (5-20 minutes)
Quench with glycine (125 mM final concentration)
Chromatin preparation:
Lyse cells using glass beads or enzymatic methods
Sonicate to fragment chromatin (200-500 bp fragments)
Verify fragment size by agarose gel electrophoresis
Immunoprecipitation conditions:
Pre-clear chromatin with Protein A beads
Use 3-5 μg SPAC26H5.05 antibody per 25-100 μg chromatin
Include appropriate controls:
Input chromatin (10%)
Non-specific IgG control
Positive control (known target)
Washing and elution:
Perform sequential washes with increasing stringency
Elute protein-DNA complexes with elution buffer
Reverse crosslinks (65°C overnight)
Purify DNA using column-based methods
Analysis methods:
qPCR for targeted analysis
Next-generation sequencing for genome-wide profiling
The success of ChIP experiments heavily depends on whether the target protein is directly or indirectly associated with DNA and whether the antibody can access the epitope in a crosslinked chromatin environment .
Computational approaches offer promising avenues for enhancing SPAC26H5.05 antibody:
Structure-based antibody engineering:
Generate 3D models of the antibody using AlphaFold2
Perform molecular docking with the target antigen
Identify key binding residues through computational alanine scanning
Design targeted mutations to improve binding affinity
In silico affinity maturation:
Implement Rosetta-based antibody design protocols
Simulate multiple rounds of somatic hypermutation
Score and rank mutant candidates
Validate top candidates experimentally
Epitope-focused antibody design:
Identify conserved epitopes across related proteins
Design antibodies specifically targeting unique epitopes
Reduce cross-reactivity through negative design principles
Machine learning approaches:
Train models on antibody-antigen binding data
Predict binding affinity and specificity for novel designs
Implement deep learning for sequence-based optimization
The IsAb computational protocol has demonstrated success in antibody design, with key steps including antigen modeling, epitope prediction, antibody modeling, docking, refinement, and affinity maturation .
SPAC26H5.05 antibody can be incorporated into advanced multiplexed detection systems:
Multiplex immunofluorescence approaches:
Sequential staining with multiple antibodies
Use spectrally distinct fluorophores for each antibody
Apply tyramide signal amplification for enhanced sensitivity
Employ multispectral imaging for signal separation
Proximity ligation assay (PLA) applications:
Combine SPAC26H5.05 with antibodies against potential interaction partners
Use species-specific PLA probes with attached oligonucleotides
Amplify signal only when proteins are in close proximity (<40 nm)
Visualize interactions as distinct puncta
Mass cytometry adaptations:
Label multiple antibodies with distinct metal isotopes
Simultaneously detect >40 proteins in single cells
Apply dimensional reduction algorithms for data analysis
Spatial transcriptomics integration:
Combine protein detection with RNA localization
Correlate protein expression with transcriptional state
Create spatial maps of protein-RNA relationships
Recent developments in single-cell protein analysis have enabled the construction of protein interaction networks with unprecedented resolution, with one study identifying 10 pairs of highly expressed clonal immunoglobulin genes using next-generation sequencing approaches coupled with antibody profiling .
For maximum stability and activity retention of SPAC26H5.05 antibody:
Short-term storage (up to 1 month):
Store at 2-8°C in the original container
Avoid repeated freeze-thaw cycles
Keep away from direct light
Long-term storage (>1 month):
Store at -20°C to -80°C in small working aliquots
Add stabilizing proteins if needed (e.g., 0.1% BSA)
Use glycerol (50% final concentration) to prevent freezing damage
Handling recommendations:
Allow antibody to equilibrate to room temperature before opening
Centrifuge briefly before opening to collect all liquid
Return to storage immediately after use
Avoid contamination by using clean pipette tips
Monitoring stability:
Record date of first use and thawing events
Periodically test reactivity against positive controls
Compare signal intensity over time
Consider preparing a standard curve for quantitative applications
Under optimal storage conditions, SPAC26H5.05 antibody typically maintains activity for at least 12 months, though performance should be validated before critical experiments .
To ensure experimental consistency across different antibody batches:
Incoming batch validation:
Perform side-by-side Western blot comparison with previous batch
Establish minimum acceptable signal-to-noise ratio
Verify specific band detection at expected molecular weight
Document batch-specific optimal dilutions
Reference standard preparation:
Create a large batch of positive control (target protein extract)
Aliquot and store at -80°C
Use as reference for all new antibody batches
Quantitative performance metrics:
Generate standard curves for each batch
Determine limit of detection and linear range
Calculate coefficient of variation between technical replicates
Compare EC50 values across batches
Documentation and record-keeping:
Maintain detailed batch records including:
Manufacturer lot number
Date received and opened
Initial validation results
Optimization parameters for specific applications
Any observed anomalies
Cross-referencing with orthogonal methods:
Validate critical findings with alternative detection methods
Consider genetic approaches (e.g., tagging) for key experiments
Implementing these measures can significantly reduce experimental variability, with studies showing that proper validation can reduce inter-batch coefficient of variation from >30% to <10% .